Showing results (141-150 of 190) with videos related to
Sort By:
Pageof 19
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2024
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinomaKelsey L Corrigan, Ting Xu, Yuki Sasaki, et al.JAMA|March 15, 2012
Association of age at diagnosis and genetic mutations in patients with neuroblastomaNai-Kong V Cheung, Jinghui Zhang, Charles Lu, et al.International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trialRitsuko Komaki, Jin Soo Lee, Luka Milas, et al.Oncotarget|February 11, 2014
RB1 gene inactivation by chromothripsis in human retinoblastomaJustina McEvoy, Panduka Nagahawatte, David Finkelstein, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2024
Receptor Tyrosine Kinase Fusion-Mediated Resistance to EGFR TKI in EGFR-Mutant NSCLC: A Multi-Center Analysis and Literature ReviewYang Xia, Kaiwen Wang, Jing Zhao, et al.Cell Reports|April 8, 2014
Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcomaXiang Chen, Armita Bahrami, Alberto Pappo, et al.BMJ Open|March 26, 2025
Precision Oncology Program (POP), an observational study using real-world data and imaging mass cytometry to explore decision support for the Molecular Tumor Board: study protocolLaura Amanda Boos, Christian Doerig, Gabriele Gut, et al.Cancer Research|May 25, 2013
Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokersXifeng Wu, Liang Wang, Yuanqing Ye, et al.Nature Communications|January 23, 2014
Integrated analysis of germline and somatic variants in ovarian cancerKrishna L Kanchi, Kimberly J Johnson, Charles Lu, et al.Cancer Cell|July 12, 2022
Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivityYasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.Pageof 19